Insta
JNU Scientists Shailaja Singh - left, Anand Ranganathan - right
Scientists at the Jawaharlal Nehru University (JNU) Anand Ranganathan and Shailaja Singh have achieved a major breakthrough in the quest to improve the efficacy of drugs like chloroquine and artemisinin in treating malaria, Deccan Herald has reported.
This breakthrough assumes significance in light of malaria parasites showing resistance to the aforementioned drugs.
The scientists at the Special Centre for Molecular Medicine in JNU have found a unique way to cripple the parasite Plasmodium falciparum before it can reach the red blood cells for multiplication.
The scientists have devised a novel approach to block the route taken by the parasite which causes cerebral malaria after discovering a block of synthetic molecules which blocks the interaction between the parasite and two proteins.
"The idea here was to break the cycle of the parasite at the very first step when it is trying to invade our RBCs. The binding of Myosin A to its physiological interacting partner (MTIP) is crucial for generating the force for parasite’s motility", Anand Ranganathan has been quoted as saying.
The scientists found that the synthetic molecule ZA1 strongly interacts with Myosin A which inhibits the parasite's motor machinery. The molecule was then truncated into a smaller ZA1s which is even better at combating the parasite.
The team now aims to crystallise these ZA1s molecules to understand its structure, following which the drug development process would begin.
Introducing ElectionsHQ + 50 Ground Reports Project
The 2024 elections might seem easy to guess, but there are some important questions that shouldn't be missed.
Do freebies still sway voters? Do people prioritise infrastructure when voting? How will Punjab vote?
The answers to these questions provide great insights into where we, as a country, are headed in the years to come.
Swarajya is starting a project with an aim to do 50 solid ground stories and a smart commentary service on WhatsApp, a one-of-a-kind. We'd love your support during this election season.
Click below to contribute.
Latest